Location History:
- Schereville, IN (US) (2015)
- Schererville, IN (US) (2017)
Company Filing History:
Years Active: 2015-2017
Title: Laura Miloshoff: Innovator in Pharmaceutical Product Development
Introduction
Laura Miloshoff, a distinguished inventor based in Schererville, IN, has made significant contributions to the pharmaceutical industry with her innovative ideas. With a total of two patents to her name, she is recognized for her forward-thinking approaches in formulating pharmaceutical products.
Latest Patents
Miloshoff's latest patents focus on a groundbreaking method for forming a pharmaceutical product directly onto a packaging surface. This invention relates specifically to creating a dissolvable film dosage form, which involves a unique process of applying pharmaceutical products onto a substrate’s surface. Her work showcases a pivotal advancement in the packaging and delivery of medications, enhancing convenience and effectiveness for users.
Career Highlights
Laura Miloshoff is a key member of Monosol Rx, LLC, a company known for its innovative solutions in drug delivery systems. Through her role, she has been instrumental in developing cutting-edge technologies that streamline pharmaceutical manufacturing and enhance consumer experience. Her expertise and contributions have positioned her as a notable figure in her field, making significant strides toward creating efficient pharmaceutical products.
Collaborations
Throughout her career, Miloshoff has collaborated with talented professionals, including Garry L. Myers and Beuford A. Bogue. These partnerships have fostered a collaborative environment, leading to creative solutions and the successful advancement of projects within Monosol Rx, LLC.
Conclusion
Laura Miloshoff's innovative spirit and dedication to her craft showcase her importance in the realm of pharmaceutical development. With her significant patents and collaborative efforts, she continues to pave the way for advancements that improve drug delivery systems, benefiting the healthcare industry and patients globally.